Hyperlactatemia and antiretroviral therapy: the Swiss HIV Cohort Study. - Wikidata - awgldk - TriplyDB

Hyperlactatemia and antiretroviral therapy: the Swiss HIV Cohort Study.

Hyperlactatemia and antiretroviral therapy: the Swiss HIV Cohort Study.

http://www.wikidata.org/entity/Q43787821

about

A risk-factor guided approach to reducing lactic acidosis and hyperlactatemia in patients on antiretroviral therapy Toxicities associated with dual nucleoside reverse-transcriptase inhibitor regimens in HIV-infected children.HIV drug stavudine (Zerit, d4T) and symptoms mimicking Guillain-Barré syndrome.Longitudinal lactate levels from routine point-of-care monitoring in adult Malawian antiretroviral therapy patients: associations with stavudine toxicities Assessment of liver fibrosis and associated risk factors in HIV-infected individuals using transient elastography and serum biomarkers.Cost-effectiveness of antiretroviral regimens in the World Health Organization's treatment guidelines: a South African analysis.Symptomatic hyperlactatemia in an HIV-positive patient: a case report and discussion.Miller Fisher variant of Guillain-Barré syndrome associated with lactic acidosis and stavudine therapy.Lactic acidosis related to nucleoside therapy in HIV-infected patients.A case of lactic acidosis caused by stavudine in an AIDS patient.Risk factors for symptomatic hyperlactatemia and lactic acidosis among combination antiretroviral therapy-treated adults in Botswana: results from a clinical trial.Fatal Tenofovir-Associateacd Lactic Acidosis: A Case Report Identification of fatigue biomarkers in treated and treatment-naive HIV patients: preliminary results.Hepatic steatosis is associated with fibrosis, nucleoside analogue use, and hepatitis C virus genotype 3 infection in HIV-seropositive patients.Current concepts in the diagnosis and management of metabolic complications of HIV infection and its therapy.Magnetic resonance imaging for quantifying regional adipose tissue in human immunodeficiency virus-infected persons with the cardiometabolic syndrome.Is it safe to switch from stavudine to zidovudine after developing symptomatic hyperlactatemia?Management of HIV-1 infection in adults Pharmacogenetic information derived from analysis of HLA alleles.Validation of an algorithm to identify antiretroviral-naïve status at time of entry into a large, observational cohort of HIV-infected patients Hyperlactatemia in a group of HIV patients living in Yaounde-Cameroon.Long term adverse effects related to nucleoside reverse transcriptase inhibitors: clinical impact of mitochondrial toxicity.Stavudine-induced hyperlactatemia/lactic acidosis at a tertiary communicable diseases clinic in South Africa.Clinical syndromes and consequences of antiretroviral-related hepatotoxicity.Mild to moderate symptoms do not correlate with lactate levels in HIV-positive patients on nucleoside reverse transcriptase inhibitors.Limitation of exercise capacity in nucleoside-treated HIV-infected patients with hyperlactataemia.Hepatic non-Hodgkin's lymphoma with lactic acidosis in HIV-infected patients: report of 2 cases.Prevalence, risk factors and outcome of hyperlactataemia in HIV-infected patients.First-line therapy and mitochondrial damage: different nucleosides, different findings.Quantitative analysis of human mitochondrial DNA using a real-time PCR assay.Prospective evaluation of blood concentration of mitochondrial DNA as a marker of toxicity in 157 consecutively recruited untreated or HAART-treated HIV-positive patients.Risk factors for hyperlactataemia in HIV-infected patients, Aquitaine Cohort, 1999--2003.Fatal nucleoside-associated lactic acidosis in an obese woman with human immunodeficiency virus type 1 infection on a very low-calorie diet.The effect of long-term storage on measured plasma lactate concentrations and prospective lactate results from a multicenter trial of antiretroviral therapy.A high incidence of lactic acidosis and symptomatic hyperlactatemia in women receiving highly active antiretroviral therapy in Soweto, South Africa.Rapid Onset of Fatal Lactic Acidosis Complicating Tenofovir Therapy in a Diabetic Patient with Cirrhosis: A Cautionary Tale.Detection of Adverse Drug Reaction Signals in the Thai FDA Database: Comparison between Reporting Odds Ratio and Bayesian Confidence Propagation Neural Network Methods

P2860

Q28477707-07792254-B889-4408-91A7-431CF5CD90A1 Q33381965-9C55A9FF-FDE1-4B01-9C6C-940C0499630B Q33575142-8605FA13-B130-4C8D-9079-7A1B7EA1FFD9 Q33621094-A8BD079A-7EAD-4815-9B3E-54D9BA714A3E Q34209648-E0DC95D4-49CA-4641-A96B-03C582D5F902 Q34768650-2653A522-C5F0-4766-ADE4-E065C586C4E6 Q35049863-57AEC070-0C28-489B-A347-78559EB9538E Q35127422-2A7F3DA9-3922-4400-8721-0C4108D1BE6B Q35183747-1193D264-4337-4066-91EE-11655643FADD Q35936783-6BD5344D-9DA7-430C-9015-852D18AE3273 Q36102516-0D0B15D5-5C87-4893-BB25-32C509078008 Q36259050-4FEEBBB9-762F-4C64-A9AC-2AAC3A2E0B23 Q36408450-1121FE91-3FB5-4C40-9595-557940C4428A Q36521414-3A3C09AB-70C9-41EC-8C06-097E69478A61 Q36555731-FBC07B13-8F84-48FB-9423-DD22A9DCDE72 Q36699841-DE336050-379E-434F-86A0-75F0D0002D0E Q36976109-B94A08B3-6E95-4DD2-AC26-B2EB8077F734 Q37061033-4F93CCA8-EBE1-4DD7-990E-5837DE5684CE Q37120841-5984A6A8-D3CB-47E2-9272-8FD66EF2FE1C Q37318637-66F16D5D-E270-4005-8872-2538794323BB Q37506855-018D901A-7DFF-4730-A2A0-99293A29DAC7 Q37634512-F05650B1-9A6E-4F5A-B144-916088A28948 Q37756440-E57CCA93-7142-4F1F-AF34-E24220A969CC Q37784777-58DB9421-31D3-4815-8BED-B538E76A5BF8 Q39764085-A76A43E0-462A-4275-8584-97E1BC675663 Q42164252-950C4866-AD37-4A62-B349-7869394E351C Q42925745-4981CD5A-4613-4C4A-A81A-149C751A7289 Q44282739-11EC5EC5-D1A9-47E8-BB51-F72E8A7FA935 Q44309069-1E7E7F83-5144-4CE4-9C19-DB77F3342454 Q44511932-8347B884-AD5D-4C9D-AFF0-2D33112924E3 Q44879927-A1591C2D-40E0-4D54-B17C-34A0D49E626A Q45288665-66312F43-0C06-4EAE-92CB-7DA36554E2E8 Q45722737-44146048-79F3-4700-8A6D-523B52A18C35 Q46714437-9ECB69F3-380E-4FB8-BD30-CF7633DD1ECD Q51749731-EB93B071-2362-44C6-A940-ADF7980B0D34 Q54841603-B7D08F0C-444C-452F-ADD2-7B0C2E44EE6C Q57175680-792B0A9C-0DCB-4D3C-A3E8-792EB58907C9

P2860

Hyperlactatemia and antiretroviral therapy: the Swiss HIV Cohort Study.

http://www.wikidata.org/entity/Q43787821

description

2001 nî lūn-bûn

@nan

2001年の論文

@ja

2001年学术文章

@wuu

2001年学术文章

@zh

2001年学术文章

@zh-cn

2001年学术文章

@zh-hans

2001年学术文章

@zh-my

2001年学术文章

@zh-sg

2001年學術文章

@yue

2001年學術文章

@zh-hant

name

Hyperlactatemia and antiretroviral therapy: the Swiss HIV Cohort Study.

@en

Hyperlactatemia and antiretroviral therapy: the Swiss HIV Cohort Study.

@nl

type

label

Hyperlactatemia and antiretroviral therapy: the Swiss HIV Cohort Study.

@en

Hyperlactatemia and antiretroviral therapy: the Swiss HIV Cohort Study.

@nl

prefLabel

Hyperlactatemia and antiretroviral therapy: the Swiss HIV Cohort Study.

@en

Hyperlactatemia and antiretroviral therapy: the Swiss HIV Cohort Study.

@nl

P1433

Q43787821-13F41521-D7BA-45B2-9C1D-32706E32D4D9

P1476

Q43787821-A864D363-BA0A-4C74-8160-033E2D88CFEC

P2093

Q43787821-165D4B93-BAC6-49E4-8F3C-8CDC2EA3699C

Q43787821-30D935C2-8B3C-4680-96B7-17AA80740430

Q43787821-3A375518-4DCE-453F-B455-0241F5A0B44B

Q43787821-72B507E1-4791-4C78-BD8D-769E270E909B

Q43787821-7CD3A4D1-A4F1-48D2-8ED3-197D556A17B8

Q43787821-81F6D4D2-B431-49F6-A2FD-A4264293D32D

Q43787821-896D0F97-1802-486C-B04F-D545514DD830

Q43787821-9E9B9DDF-A2FF-4C46-9C12-194A09541A80

Q43787821-A9DBA175-3E53-4252-8F03-0AED1A691B80

Q43787821-B74BF46A-7890-4DE1-ADCB-49E58804967D

P2860

Q43787821-0C420CB7-B936-41CC-94C6-8A0D968C8082

Q43787821-1454AFE2-CF39-4FA4-918B-2A44D2791AF7

Q43787821-179E5409-347D-40D2-B17E-8ED0F090245F

Q43787821-1DDF47E0-388B-4B2A-98DE-9E65D9CAF159

Q43787821-2804ED7D-8085-47BC-9422-25B7A9958C05

Q43787821-33C359AD-8664-449C-82D7-DB80D0588233

Q43787821-4C87001B-5A40-417A-98B9-CDD5C39C2AAB

Q43787821-4CBF615A-FA48-407F-82B8-68A65EA9DAC4

Q43787821-5B43CF0A-B00B-4287-824F-3095001E84D7

Q43787821-5C0A7A0D-9459-4CE2-9A88-0CE473A4FCCE

P304

Q43787821-65CC6F0B-5149-45F9-954C-D297A1245D62

P31

Q43787821-EEFE121C-C7D8-4106-80C8-3A6AC2A05FBD

P356

Q43787821-BBE9F471-20B2-46DF-80A4-C73757F61D86

P407

Q43787821-149CC182-F808-4ECB-9D12-295976043C7D

P433

Q43787821-881533F4-4819-4F29-8EC4-AA8E7F7E4169

P478

Q43787821-2E678D49-50A9-4128-BB41-F9E18ECA56BF

P50

Q43787821-A79F0C85-C43E-49A4-B5B6-AA92D4D974F4

P577

Q43787821-F08883AD-551E-4EF7-9CE9-F318031B9C9D

P5875

Q43787821-7C76D70D-A47F-419B-82B1-15CCE585A5FA

P698

Q43787821-4A98C7C0-4419-48C5-B400-683A9F8833FF

P356

P1433

Clinical Infectious Diseases

P1476

Hyperlactatemia and antiretroviral therapy: the Swiss HIV Cohort Study.

@en

P2093

Bernasconi E

http://www.w3.org/2001/XMLSchema#string

Boggian K

http://www.w3.org/2001/XMLSchema#string

Boubaker K

http://www.w3.org/2001/XMLSchema#string

Chave JP

http://www.w3.org/2001/XMLSchema#string

Flepp M

http://www.w3.org/2001/XMLSchema#string

Francioli P

http://www.w3.org/2001/XMLSchema#string

Furrer H

http://www.w3.org/2001/XMLSchema#string

Haensel A

http://www.w3.org/2001/XMLSchema#string

Hirschel B

http://www.w3.org/2001/XMLSchema#string

Opravil M

http://www.w3.org/2001/XMLSchema#string

P2860

Depletion of muscle mitochondrial DNA in AIDS patients with zidovudine-induced myopathy

Fulminant hepatic failure associated with 2',3'-dideoxyinosine (ddI)

Mitochondrial myopathy caused by long-term zidovudine therapy

Incidence of neuropathy in HIV-infected patients on monotherapy versus those on combination therapy with didanosine, stavudine and hydroxyurea

Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy.

Mitochondrial respiratory chain disorders I: mitochondrial DNA defects.

Lactic acidosis associated with stavudine administration: a report of five cases.

Differential effects of antiretroviral nucleoside analogs on mitochondrial function in HepG2 cells.

Fulminant hepatitis with severe lactate acidosis in HIV-infected patients on didanosine therapy.

Chronic hyperlactatemia in HIV-infected patients taking antiretroviral therapy.

P304

1931-1937

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1086/324353

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

33

http://www.w3.org/2001/XMLSchema#string

P50

P577

2001-10-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11662484

http://www.w3.org/2001/XMLSchema#string

P698

11692306

http://www.w3.org/2001/XMLSchema#string